Notice Inviting Tender (NIT) by the Central Government And Public Sector Of India for Gem Bids For Nebivolol 5mg Tab, Telmisartan 40 Mg Plushydrochlorothiazide 12 Point 5 Mg Tab, Betamethasonedipropionate 0 Point 025 Percent W By W Neomycin 0point 5percent W By W Clotrimazole 1 Percent W By Wcream Tube Of 20g, Povidone Iodine Solution 5 Percentbottle Of 100 Ml, Tab Dutasteride 0 Point 5 Mg, Pancreaticenzyme Supplement With A Lipase Content Of 25000 Units Ormore Cap, Antispasmodic Tab Containing Mefenamic Acid250 Mg And Dicyclomine Hcl 10 Mg, Clarithromycin500mg Tab, Trypsin With Chymotrypsin Tab, Drotaverinehcl 20mg Per Ml Inj, Hyoscine Bromide Inj 20 Mg Per Ml1ml Inj, Pancreatic Enzyme Capsules With A Lipase Contentof 10000 To 20000 Units, Loperamide 2mg Tab, Prednisolone 20 Mg Tab, Metformin 1000 Mg Plusvildagliptin 50 Mg Tab, Voglibose 0 Point 2 Mg Tab, Glibenclamide 5mg Tab, Tab Vildagliptin 50 Mg, Insulinhighly Purified Isophane Human Nph 40 Iu Per Ml 10 Ml Inj, Tab Metformin 500 Mg Plus Tab Vildagliptin 50 Mg, Gatifloxacin 0 Point 3 Percent Eye Drop Bott Of 5 Ml, Carboxy Methyl Cellulose 1 Percent Eye Drop Bott Of 10 Ml, Ofloxacin 0 Point 3 Percent Bott Of 5 Ml, Syp Dicyclominedrops Of 15 Ml, Lorazepam 1 Mg Tab, Etophylline Bp 84point 7 Mg And Theophylline Ip 25 Point 3 Mg Per Ml 2 Mlinj, N Acetyl Cysteine 600 Mg Tab in Hyderabad - Telangana has been published.
The last date of this tender is 18/07/2025, work value is  0 (Refer Doc) INR, EMD is  0 (Refer Doc) INR and tender document fees is  0 (Refer Doc) INR
For more details call us on +91 92760 83333 for bidding support this tender, GeM, vendor registration (if any) and tender BOQ documents.

Tender Document

Related Information

Location

Hyderabad - Telangana ( IN )

Ownership

Central Government And Public Sector Of India

Sector

Security Services

Important Dates

Published on

03 Jul, 2025

Submission Date

18 Jul, 2025

Opening Date

18 Jul, 2025

Key Values

Work Value

Refer Doc

EMD

Refer Doc

Document Fee

Refer Doc
Tender Document Liaison Service Connect with us